Synonym
Dihydroetorphine; 14357-76-7; QQX8S479YV; 18,19-Dihydroetorphine; UNII-QQX8S479YV
IUPAC/Chemical Name
(4R,4aS,6R,7R,7aR,12bS)-6-((R)-2-hydroxypentan-2-yl)-7-methoxy-3-methyl-1,2,3,4,5,6,7,7a-octahydro-4a,7-ethano-4,12-methanobenzofuro[3,2-e]isoquinolin-9-ol
InChi Key
BRTSNYPDACNMIP-FAWZKKEFSA-N
InChi Code
InChI=1S/C25H35NO4/c1-5-8-22(2,28)17-14-23-9-10-25(17,29-4)21-24(23)11-12-26(3)18(23)13-15-6-7-16(27)20(30-21)19(15)24/h6-7,17-18,21,27-28H,5,8-14H2,1-4H3/t17-,18-,21-,22-,23-,24+,25-/m1/s1
SMILES Code
[H][C@@]12OC3=C(O)C=CC4=C3[C@@]15CCN(C)[C@]([H])(C4)[C@]56CC[C@@]2(OC)[C@]([H])(C6)[C@](C)(O)CCC
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
413.56
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Ohmori S, Morimoto Y. Dihydroetorphine: a potent analgesic: pharmacology,
toxicology, pharmacokinetics, and clinical effects. CNS Drug Rev. 2002
Winter;8(4):391-404. doi: 10.1111/j.1527-3458.2002.tb00236.x. PMID: 12481194;
PMCID: PMC6741694.
2: Kamei J, Iwamoto Y, Suzuki T, Misawa M, Nagase H, Kasuya Y. Antitussive
effect of dihydroetorphine in mice. Eur J Pharmacol. 1994 Aug 1;260(2-3):257-9.
doi: 10.1016/0014-2999(94)90347-6. PMID: 7988653.
3: Kamei J, Suzuki T, Nagase H. Agonist and antagonist properties of
dihydroetorphine for mu-opioid receptors in mice. Neurosci Lett. 1996 Sep
6;215(2):87-90. PMID: 8888002.
4: Wang DX, Lu XQ, Qin BY. Dihydroetorphine is a mu-receptor-selective ligand. J
Pharm Pharmacol. 1995 Aug;47(8):669-73. doi: 10.1111/j.2042-7158.1995.tb05857.x.
PMID: 8583370.
5: Liu F, Luo Y, Feng J, Hu X. Determination of dihydroetorphine in biological
fluids by gas chromatography-mass spectrometry using selected-ion monitoring. J
Chromatogr B Biomed Appl. 1996 Apr 26;679(1-2):113-8. doi:
10.1016/0378-4347(96)00044-8. PMID: 8998549.
6: Katsumata S, Minami M, Nakagawa T, Iwamura T, Satoh M. Pharmacological study
of dihydroetorphine in cloned mu-, delta- and kappa-opioid receptors. Eur J
Pharmacol. 1995 Nov 30;291(3):367-73. doi: 10.1016/0922-4106(95)90078-0. PMID:
8719422.
7: Ohmori S, Hayashi T, Kawase M, Saito S, Sugibayashi K, Morimoto Y.
Transdermal delivery of the potent analgesic dihydroetorphine: kinetic analysis
of skin permeation and analgesic effect in the hairless rat. J Pharm Pharmacol.
2000 Dec;52(12):1437-49. doi: 10.1211/0022357001777649. PMID: 11197071.
8: Niwa M, al-Essa LY, Ohta S, Kohno K, Nozaki M, Tsurumi K, Iwamura T, Kataoka
T. Opioid receptor interaction and adenylyl cyclase inhibition of
dihydroetorphine: direct comparison with etorphine. Life Sci.
1995;56(21):PL395-400. doi: 10.1016/0024-3205(95)00156-z. PMID: 7739347.
